Familial transthyretin-type amyloid polyneuropathy in Japan
Top Cited Papers
- 9 April 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Neurology
- Vol. 58 (7) , 1001-1007
- https://doi.org/10.1212/wnl.58.7.1001
Abstract
Familial amyloid polyneuropathy (FAP) was once considered a disease peculiar to endemic areas, but it is now recognized not to be a rare disease among hereditary neuropathic disorders in Japan. FAP in Japan, the majority of which is caused by transthyretin (TTR)-related amyloid deposition, shows a wide spectrum of clinical pictures. This variability can be explained on the basis of the many causative gene mutations of TTR, but even in the same TTR type of FAP, the clinical phenotypes seem to vary in different kindreds or individuals. Especially in the case of the Val30Met TTR type, the sex ratio and the age at onset are considerably different between patients in endemic foci and those in nonendemic areas. It is also noteworthy that serious cardiac amyloidosis is commonly seen in patients with FAP of the non-Val30Met TTR type. In addition to TTR gene mutation, unknown factors may play an important role in the development of FAP. At present, liver transplantation is the only life-saving treatment, but this therapy is always associated with great stress for the patient and the donor, particularly in living-related transplantation. Less invasive treatments for this disease are required.Keywords
This publication has 72 references indexed in Scilit:
- Cardiac Amyloid in Patients with Familial Amyloid Polyneuropathy Consists of Abundant Wild-Type TransthyretinBiochemical and Biophysical Research Communications, 2000
- A Novel Compound Heterozygote (FAP ATTR Arg104His/ATTR Val30Met) with High Serum Transthyretin (TTR) and Retinol Binding Protein (RBP) LevelsBiochemical and Biophysical Research Communications, 1999
- A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy.Journal of Medical Genetics, 1998
- A Basic Transthyretin Variant (GLU61→LYS) Causes Familial Amyloidotic Polyneuropathy: Protein and DNA Sequencing and PCR-Induced Mutation Restriction AnalysisBiochemical and Biophysical Research Communications, 1993
- A novel transthyretin mutation associated with familial amyloidotic polyneuropathyBiochemical and Biophysical Research Communications, 1992
- New mutant gene (transthyretin Arg 58) in cases with hereditary polyneuropathy detected by non-isotope method of single-strand conformation polymorphism analysisBiochemical and Biophysical Research Communications, 1991
- A novel variant of transthyretin (Tyr114 to Cys) deduced from the nucleotide sequences of gene fragments from familial amyloidotic polyneuropathy in Japanese sibling casesBiochemical and Biophysical Research Communications, 1990
- Diagnosis of familial amyloidotic polyneuropathy by recombinant DNA techniquesBiochemical and Biophysical Research Communications, 1984
- Radioimmunoassay for detecting abnormal prealbumin in the serum for diagnosis of familial amyloidotic polyneuropathy (Japanese type)Biochemical and Biophysical Research Communications, 1984
- Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type)Biochemical and Biophysical Research Communications, 1983